These success, together with a previous report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 support the notion of targeting ACKR3 as a singular strategy to modulate the opioid technique, which could open up new therapeutic avenues for opioid-related Diseases. By ticking this box and https://augustinek395euq2.prublogger.com/profile